851729-01-6Relevant articles and documents
CB1 RECEPTOR MODULATORS
-
Page/Page column 52; 53; 55; 56, (2008/12/06)
Compounds of formula (I) suppress the normal signalling activity CB1 receptors, and are thus useful in the treatment of diseases or conditions which are mediated by CB1 receptor signalling activity, such as treatment of obesity and overweight, prevention
Process for Preparing Bicyclic Pyrazolyl
-
Page/Page column 15-16, (2010/11/28)
A process for preparing compounds of Formula (I) is described herein. The compounds have been shown to act as cannabinoid receptor ligands and are therefore useful in the treatment of disease linked to the mediation of the cannabinoid receptors in animals.
Bicyclic pyrazolyl and imidazolyl compounds and uses thereof
-
Page/Page column 35-36, (2010/02/11)
Compounds of Formula (I) are described herein. The compounds have been shown to act as cannabinoid receptor ligands and are therefore useful in the treatment of diseases linked to the mediation of the cannabinoid receptors in animals.